Psychiatry

814 questions

Question 681Question →

An occupational health physician is evaluating a 49-year-old male warehouse manager due to unintended sleep episodes at work over the past 7 months. The patient states, 'No matter how early I go to bed, I wake up with a morning headache and feel exhausted.' His bed partner recently moved to a separate bedroom due to his disruptive, loud snoring and intermittent gasping sounds during the night. Medical history is notable for essential hypertension and bipolar II disorder, which has been stable on lamotrigine for five years. Current medications include lisinopril and lamotrigine. His body mass index is 36 kg/m236 \text{ kg/m}^2. Vital signs are within normal limits. Physical examination reveals a crowded oropharynx and 1+ bilateral pitting edema in the lower extremities. Laboratory studies reveal a normal thyroid-stimulating hormone level of 1.9 \muU/mL1.9 \text{ \mu U/mL} and a normal free T4 level. The patient expresses concern because a previous physician mentioned a 'borderline low thyroid hormone' level years ago. Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Order an overnight polysomnography

Answer

Order an overnight polysomnography
The clinical presentation of excessive daytime sleepiness, nonrestorative sleep, morning headaches, loud snoring, and witnessed gasping in an overweight male strongly suggests obstructive sleep apnea (OSA). A crowded oropharynx and elevated body mass index further increase the pretest probability. The definitive next step for diagnosing OSA is an overnight polysomnography (sleep study), which measures the apnea-hypopnea index (AHI) to confirm the diagnosis and guide subsequent therapy.

Step-by-Step Solution

1
Identify the classic clinical presentation of the patient's sleep disturbance.
The patient exhibits excessive daytime sleepiness, nonrestorative sleep, morning headaches, loud snoring, and witnessed apneas (gasping).
Recognizing this symptom cluster is essential to suspect Obstructive Sleep Apnea (OSA).
2
Evaluate risk factors and physical examination findings.
The patient has a high body mass index (36 kg/m236 \text{ kg/m}^2) and a crowded oropharynx, which heavily predispose him to upper airway collapse.
Physical attributes confirm the high pretest probability of OSA.
3
Select the most appropriate initial diagnostic investigation.
An in-lab overnight polysomnography is required to measure the apnea-hypopnea index (AHI) and formally diagnose the condition.
Objective confirmation of sleep-disordered breathing is necessary before initiating continuous positive airway pressure (CPAP) or other therapies.

Key Concept

Diagnosis of Obstructive Sleep Apnea (OSA)
Question 682Question →

A 28-year-old woman is brought to the emergency department by her sister due to severe agitation and paranoia. The sister reports that the patient has been awake for three days, pacing her apartment, and claiming that government agents are watching her through the smoke detectors. The patient has a past psychiatric history of bipolar I disorder. The sister suspects the patient recently began using "meth" (methamphetamine). The patient's medical record indicates that her father is her legally appointed healthcare proxy. Vital signs are temperature 38.2°C (100.8°F), blood pressure 165/100 mm Hg, pulse 122/min, and respirations 22/min. Physical examination shows diaphoresis, mydriasis, and extensive excoriations on her face and arms. She is highly combative, actively attempting to strike the nursing staff, and screaming, "I won't let you poison me!" Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Administer intravenous lorazepam

Answer

The most appropriate next step in the management of this patient is to administer intravenous lorazepam.
The patient's presentation of severe agitation, paranoia, tactile hallucinations (suggested by the skin excoriations), mydriasis, diaphoresis, tachycardia, and hypertension is highly characteristic of acute methamphetamine intoxication. In the emergency setting, the primary goals of managing stimulant intoxication are to ensure patient and staff safety, control agitation, and prevent cardiovascular complications (e.g., myocardial infarction, stroke) and seizures. Benzodiazepines, such as intravenous lorazepam or diazepam, are the first-line treatment. They enhance GABA-A receptor activity, which suppresses the central nervous system hyperarousal, thereby effectively controlling both the severe agitation and the sympathomimetic hyperdynamic state (tachycardia and hypertension).

Step-by-Step Solution

1
Evaluate the clinical presentation and vital signs.
The patient exhibits severe agitation, paranoia, tactile hallucinations (evidenced by excoriations), mydriasis, diaphoresis, hyperthermia, tachycardia, and hypertension after suspected methamphetamine use.
Establishing the clinical toxidrome is required to correctly identify the primary cause of the acute behavioral and physical abnormalities.
2
Diagnose the underlying acute condition.
The constellation of a sympathomimetic toxidrome combined with psychotic features confirms acute methamphetamine intoxication.
Accurate diagnosis is crucial to select the correct pharmacological intervention and avoid contraindicated treatments.
3
Determine the most appropriate immediate management step.
Select intravenous lorazepam to treat the acute agitation and reverse the sympathomimetic hyperactivity.
Benzodiazepines safely reduce central nervous system hyperarousal, controlling the combative behavior and protecting against cardiovascular collapse and seizures.

Key Concept

Acute methamphetamine intoxication presents with a sympathomimetic toxidrome and agitation, and the first-line pharmacological treatment is benzodiazepines.
Question 683Question →

A 32-year-old man with a 10-year history of treatment-resistant schizophrenia is evaluated on the inpatient psychiatric unit. Over the past several years, he has continued to experience severe, commanding auditory hallucinations despite adequate therapeutic trials of risperidone, olanzapine, and haloperidol. Four weeks ago, he was transitioned to clozapine, which was gradually titrated to 600 mg daily. The nursing staff notes that his psychotic symptoms have dramatically improved, and he is interacting appropriately with peers for the first time in years. However, earlier today, the patient experienced a new-onset generalized tonic-clonic seizure that lasted 90 seconds and spontaneously resolved. He has no prior history of seizures, and a non-contrast head CT is unremarkable. His current absolute neutrophil count is 4,500/mm³. Which of the following is the most appropriate next step in the pharmacologic management of this patient?

Show answer & explanation

Answer: Add valproic acid and reduce the clozapine dose

Answer

Add valproic acid and reduce the clozapine dose
The correct approach is to reduce the clozapine dose and add valproic acid. This patient has treatment-resistant schizophrenia and is showing significant clinical improvement on clozapine. Clozapine is highly effective for refractory cases but carries a known, dose-dependent risk of seizures, particularly at doses greater than 600 mg daily. When a seizure occurs in a patient deriving substantial psychiatric benefit from clozapine, the medication should not be abandoned. Instead, the standard of care is to lower the dose to reduce the seizure threshold risk and concurrently initiate an antiepileptic drug. Valproic acid is the anticonvulsant of choice because it provides excellent broad-spectrum coverage and does not cause bone marrow suppression, avoiding a dangerous synergistic interaction with clozapine.

Step-by-Step Solution

1
Identify the etiology of the new-onset seizure in this patient.
The seizure is an adverse effect of high-dose clozapine (600 mg daily).
Clozapine lowers the seizure threshold in a strong, dose-dependent manner.
2
Determine whether clozapine should be discontinued.
Clozapine should be continued with adjustments.
The patient has treatment-resistant schizophrenia and is experiencing significant improvement for the first time; the side effect can be managed without completely abandoning the drug.
3
Select the appropriate pharmacologic management for the seizure.
Reduce the clozapine dose and add valproic acid.
Dose reduction decreases the immediate seizure risk, and valproic acid provides antiepileptic coverage without compounding clozapine's risk of bone marrow suppression.

Key Concept

Management of clozapine-induced seizures in treatment-resistant schizophrenia
Estimated Time:1m 30s
Question 684Question →

A 26-year-old man with a recent diagnosis of schizophrenia is initiated on oral haloperidol therapy to manage severe psychotic symptoms. Arrange the following potential medication-induced movement disorders in the standard chronological order of their expected onset, from the earliest to appear to the latest.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological order of onset is: Acute dystonia (earliest), Akathisia, Parkinsonism, and Tardive dyskinesia (latest).
Extrapyramidal side effects emerge in a highly predictable sequence based on the duration of D2 receptor blockade. Acute dystonia is an immediate crisis occurring in hours to days. Akathisia follows in days to weeks. Drug-induced parkinsonism develops over weeks to months. Tardive dyskinesia is a late consequence requiring months to years of exposure.

Step-by-Step Solution

1
Identify the underlying medication and its associated adverse effects.
Haloperidol is a high-potency first-generation antipsychotic heavily associated with extrapyramidal symptoms (EPS).
Recognizing the drug class confirms that the presented symptoms represent classic EPS, which follow a specific temporal pattern.
2
Sequence the acute and subacute complications.
Sustained neck contraction describes acute dystonia (hours to days). The urge to move describes akathisia (days to weeks).
These are the earliest manifestations of D2 receptor blockade in the nigrostriatal tract.
3
Sequence the delayed and long-term complications.
Resting tremor and bradykinesia describe parkinsonism (weeks to months). Lip-smacking describes tardive dyskinesia (months to years).
Parkinsonism requires sustained dopamine blockade, while tardive dyskinesia results from long-term receptor upregulation and supersensitivity.

Key Concept

The chronological onset of antipsychotic-induced extrapyramidal symptoms follows a predictable timeline: acute dystonia (hours to days), akathisia (days to weeks), parkinsonism (weeks to months), and tardive dyskinesia (months to years).

Alternative Method

The 'Rule of 4s' mnemonic is highly effective for remembering this timeline: 4 hours (Acute dystonia), 4 days (Akathisia), 4 weeks (Parkinsonism), 4 months (Tardive dyskinesia).
Estimated Time:1m 0s
Question 685Question →

A 32-year-old woman with a history of severe, treatment-resistant major depressive disorder is evaluated in the psychiatry clinic. She has experienced minimal clinical improvement on an optimized dose of fluoxetine over the past 12 weeks. The psychiatrist decides to discontinue fluoxetine and initiate phenelzine. To prevent life-threatening complications such as serotonin syndrome and hypertensive crisis, strict guidelines must be followed during this transition and in the event of future medication changes. Arrange the following clinical management steps in the correct chronological sequence required to safely execute this treatment plan.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence is to first discontinue fluoxetine, then observe a 5-week washout period, followed by initiating phenelzine with a tyramine-restricted diet, and finally maintaining those restrictions for 2 weeks if phenelzine is ever discontinued.
The sequence correctly accounts for the pharmacokinetic and pharmacodynamic properties of fluoxetine and phenelzine. Fluoxetine must be stopped first, followed by a mandatory 5-week washout due to the long half-life of its active metabolite norfluoxetine. Only then can phenelzine and a low-tyramine diet be initiated. If phenelzine is later stopped, its irreversible MAO inhibition requires restrictions to continue for 2 weeks while the body synthesizes new enzymes.

Step-by-Step Solution

1
Discontinue the administration of fluoxetine.
Blood levels of fluoxetine and its active metabolites begin to slowly decline.
Concomitant use of SSRIs and MAOIs is absolutely contraindicated due to the high risk of fatal serotonin syndrome.
2
Maintain a strict 5-week medication-free washout period.
Sufficient clearance of the SSRI from the patient's system is achieved.
Fluoxetine has a uniquely long half-life (up to 7-15 days for norfluoxetine), necessitating a 5-week washout rather than the standard 2-week washout required for most other SSRIs.
3
Initiate phenelzine therapy while concurrently starting a low-tyramine diet.
Irreversible inhibition of monoamine oxidase begins safely without excess systemic serotonin or tyramine.
Once the SSRI is cleared, the MAOI can be started. The tyramine-restricted diet is necessary to prevent a sympathomimetic hypertensive crisis.
4
Maintain the low-tyramine diet and avoid serotonergic agents for 2 weeks if phenelzine is ever discontinued.
The patient remains safe from drug-food and drug-drug interactions until native enzyme function is restored.
Irreversible MAOIs permanently deactivate existing MAO enzymes. It takes the body approximately 2 weeks to synthesize new MAO enzymes after the drug is stopped.

Key Concept

Cross-tapering protocols between serotonergic agents and MAOIs require specific washout periods to prevent serotonin syndrome: 5 weeks after stopping fluoxetine, and 2 weeks after stopping an MAOI.
Estimated Time:1m 30s
Question 686Question →

A 26-year-old woman is evaluated in the sleep clinic for a 1-year history of irresistible daytime sleep attacks. She reports frequently falling asleep during meetings and while driving. Additionally, she experiences vivid, frightening hallucinations just as she is falling asleep, and transient periods of bilateral leg weakness triggered by sudden laughter. She takes no medications and her physical examination is unremarkable. Arrange the following steps in the most appropriate chronological sequence for the diagnostic evaluation and step-wise pharmacological management of this patient.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: 1) Review a two-week sleep diary, 2) Conduct an overnight polysomnography, 3) Perform a Multiple Sleep Latency Test (MSLT), 4) Initiate modafinil, 5) Add venlafaxine.
The evaluation of suspected narcolepsy type 1 begins with a sleep diary to verify that excessive daytime sleepiness is not simply due to chronic sleep deprivation. Next, an overnight polysomnography (PSG) is strictly required to rule out other sleep disorders (e.g., sleep apnea) and to document at least 6 hours of sleep. The following day, a Multiple Sleep Latency Test (MSLT) is performed to objectively confirm narcolepsy by demonstrating a mean sleep latency of less than 8 minutes and at least two sleep-onset REM periods. Therapeutically, the stepwise approach first addresses excessive daytime sleepiness with a wake-promoting agent like modafinil. Once daytime wakefulness is improved, targeted therapy for cataplexy (emotionally triggered muscle weakness) is added using an REM-suppressing medication such as an SNRI (e.g., venlafaxine).

Step-by-Step Solution

1
Evaluate the initial diagnostic requirement.
A sleep diary is reviewed.
To establish baseline sleep-wake patterns and rule out chronic sleep deprivation or circadian rhythm disorders prior to formal objective testing.
2
Determine the first objective diagnostic study.
Overnight polysomnography is conducted.
To rule out co-occurring sleep disorders such as obstructive sleep apnea and to confirm the patient has slept enough (at least 6 hours) to validate subsequent daytime testing.
3
Determine the confirmatory diagnostic test.
Multiple Sleep Latency Test (MSLT) is performed.
Conducted the day after polysomnography to detect a shortened sleep latency (under 8 minutes) and at least two sleep-onset REM periods (SOREMPs), which confirms narcolepsy.
4
Establish the initial pharmacological intervention.
Modafinil is prescribed.
Wake-promoting agents are the first-line treatment for managing excessive daytime sleepiness, which is generally the most pervasive and debilitating symptom.
5
Address the patient's cataplexy.
Venlafaxine is added to the regimen.
An SNRI strongly suppresses REM sleep and is highly effective at preventing the emotionally triggered sudden loss of muscle tone (cataplexy) seen in narcolepsy type 1.

Key Concept

Diagnosis and Stepwise Management of Narcolepsy Type 1
Question 687Question →

A mother schedules a pediatric consultation for her four-and-a-half-year-old son because she feels overwhelmed by his constant need to move. The mother describes the child as being 'driven by a motor,' noting that he routinely climbs on top of the refrigerator, sprints down the hallways, and constantly interrupts her conversations. She is convinced he has a medical condition and wants a prescription to calm him. Developmentally, the child can hop on one foot, copy a cross on paper, and speak in completely intelligible sentences. A behavior rating scale completed by his preschool teacher reveals that the child participates cooperatively in group games, sits attentively during fifteen-minute story sessions, and shares toys with peers appropriately. His physical examination, including vision and hearing screens, reveals no abnormalities. Which of the following is the most appropriate management for this patient?

Show answer & explanation

Answer: Provide education regarding age-appropriate expectations

Answer

Provide education regarding age-appropriate expectations
The correct answer involves educating the caregiver about normal pediatric development. This four-and-a-half-year-old boy exhibits high energy and active behavior at home but functions perfectly well in a structured preschool environment, where he engages cooperatively with peers and follows classroom rules. According to DSM-5 criteria, a diagnosis of Attention-Deficit/Hyperactivity Disorder (ADHD) requires that hyperactive, impulsive, or inattentive symptoms be present in two or more settings (e.g., home and school) and cause significant functional impairment. Because this child's symptoms are isolated solely to the home setting and his developmental milestones (copying a cross, hopping on one foot, demonstrating completely intelligible speech) are appropriate for his age, his presentation is consistent with normal high activity of childhood rather than a neurodevelopmental disorder. Therefore, the best management is to educate the mother on age-appropriate behavioral expectations.

Step-by-Step Solution

1
Evaluate the patient's symptoms against the diagnostic criteria for ADHD.
The patient exhibits hyperactivity only at home, with no symptoms of inattention or hyperactivity in the preschool setting.
DSM-5 criteria for ADHD require symptoms to be present in at least two different settings and cause significant functional impairment.
2
Assess the patient's developmental milestones for his age.
Hopping on one foot, copying a cross, and using fully intelligible speech are normal and expected milestones for a four-and-a-half-year-old child.
Distinguishing pathological developmental delay or neurodivergence from normal behavior requires confirming that milestones are age-appropriate.
3
Determine the appropriate clinical intervention based on the diagnostic findings.
The appropriate action is to educate the mother on normal childhood behavior.
Since the child's behavior is age-appropriate and does not meet criteria for any psychiatric disorder, medical interventions are contraindicated.

Key Concept

Attention-Deficit/Hyperactivity Disorder (ADHD) requires symptoms to be present in two or more settings; highly active behavior restricted to a single environment in a preschooler is typically a normal developmental variant.
Question 688Question →

A 31-year-old man is brought to the emergency department by his roommate due to increasingly erratic behavior over the past week. The patient is pacing rapidly, speaking tangentially, and claims he has discovered a mathematical formula that will solve world hunger. He states he has not slept in four days. He also reports hearing the voice of a historical figure giving him constant instructions. Review of his medical record reveals a psychiatric history beginning at age 24. Since that time, he has experienced multiple prolonged episodes of both severe depression and mania, which collectively account for more than half of the total duration of his illness. The records also clearly document a notable 4-month period last year when his mood was entirely stable and euthymic, yet he continued to experience persistent auditory hallucinations and the delusion that foreign agents were monitoring his thoughts. Urine toxicology screen is negative. Which of the following is the most accurate diagnosis?

Show answer & explanation

Answer: Schizoaffective disorder

Answer

The most accurate diagnosis is schizoaffective disorder.
The correct answer identifies schizoaffective disorder. This diagnosis requires an uninterrupted period of illness featuring a major mood episode (mania or depression) concurrent with Criterion A symptoms of schizophrenia (e.g., delusions, hallucinations). Crucially, to differentiate it from a mood disorder with psychotic features, psychotic symptoms must be present for at least 2 weeks in the absence of a major mood episode. Furthermore, to differentiate it from schizophrenia, the mood episodes must be present for the majority of the total active and residual illness duration. This patient has a history of major mood episodes accounting for more than half of his illness, alongside a clear documented 4-month period of psychotic symptoms occurring during euthymia.

Step-by-Step Solution

1
Identify the primary symptom clusters present in the clinical vignette.
The patient exhibits both prominent psychotic symptoms (hallucinations, delusions) and prominent mood symptoms (mania, severe depression).
Establishing the presence of both domains is required to formulate the initial differential diagnosis for schizoaffective vs primary mood vs primary psychotic disorders.
2
Analyze the temporal relationship between the psychotic symptoms and the mood episodes.
The patient experienced persistent auditory hallucinations and delusions for a 4-month period while his mood was entirely stable and euthymic.
Psychosis occurring for 2 or more weeks in the absence of a major mood episode is the critical distinguishing feature that rules out a mood disorder with psychotic features.
3
Evaluate the longitudinal history of the illness to determine the overall proportion of mood symptoms.
Major mood episodes account for more than half (the majority) of the total duration of the patient's illness.
If mood episodes are present for the majority of the illness, it meets criteria for schizoaffective disorder; if they account for only a minority of the duration, the diagnosis would be schizophrenia.

Key Concept

Schizoaffective disorder requires psychotic symptoms to be present for ≥2 weeks in the absence of a major mood episode, AND major mood episodes must be present for the majority of the total illness duration.
Question 689Question →

A 42-year-old man presents to the psychiatric clinic for the management of a newly diagnosed major depressive disorder (MDD). Over the next 18 months, his clinical course is characterized by significant treatment resistance, eventually leading to a severe exacerbation with psychotic features and food refusal. Arrange the following therapeutic interventions in the correct chronological order according to standard stepped-care pharmacologic and somatic treatment guidelines for MDD, starting from his initial presentation to his most severe exacerbation.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence of treatment escalation for major depressive disorder is: 1) initial SSRI/SNRI monotherapy, 2) switching to an alternative monotherapy upon non-response, 3) augmentation with a secondary agent (e.g., atypical antipsychotic) for partial response, and finally 4) electroconvulsive therapy for severe, treatment-resistant, or psychotic depression.
The correct sequence follows the evidence-based stepped-care model for MDD: initial monotherapy, switching monotherapies if there is no response, utilizing augmentation strategies if there is a partial response, and reserving electroconvulsive therapy for severe, refractory, or psychotic cases.

Step-by-Step Solution

1
Identify the standard first-line treatment for uncomplicated MDD.
Initiation of SSRI monotherapy.
SSRIs have a favorable side effect profile and are the standard initial pharmacotherapy for MDD.
2
Determine the next step for a patient with zero response to an adequate initial trial.
Switching to a different antidepressant (e.g., SNRI).
Non-responders benefit more from switching to a different agent, whereas partial responders are candidates for augmentation.
3
Determine the management for a patient showing partial response to a subsequent monotherapy.
Augmentation with a second-generation antipsychotic or lithium.
Augmentation strategies build upon the partial efficacy of the current regimen to achieve remission in treatment-resistant cases.
4
Identify the definitive treatment for severe depression with life-threatening psychotic features.
Electroconvulsive therapy (ECT).
ECT provides rapid, highly effective relief for psychotic depression and when a patient's health is acutely compromised (e.g., food refusal).

Key Concept

The stepped-care approach to Major Depressive Disorder escalates from initial monotherapy, to switching agents for non-response, to augmentation for partial response, and ultimately to electroconvulsive therapy for refractory or psychotic depression.
Question 690Question →

A 35-year-old woman is being managed for cocaine use disorder over a period of three years. Her readiness to modify her substance use behavior fluctuates over time. According to the Transtheoretical Model of Change, arrange the following patient statements in the expected chronological progression from the earliest stage of behavior change to the latest.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological progression through the Stages of Change is: Precontemplation, Contemplation, Preparation, Action, and finally Maintenance.
The Transtheoretical Model of Change describes a sequential process of behavioral modification, particularly useful in assessing a patient's readiness for substance use disorder treatment. The stages progress from Precontemplation (not recognizing the problem), to Contemplation (recognizing the problem but ambivalent about change), to Preparation (intending to take action and taking small steps), to Action (making specific, overt modifications in lifestyle), and finally to Maintenance (working to prevent relapse and consolidate gains).

Step-by-Step Solution

1
Analyze the question requirements.
The question asks to order statements according to the Transtheoretical Model of Change.
This model describes the sequential stages individuals progress through when modifying addictive behaviors.
2
Categorize each statement.
Statement 1 is Precontemplation (denial). Statement 2 is Contemplation (ambivalence). Statement 3 is Preparation (planning). Statement 4 is Action (recent abstinence). Statement 5 is Maintenance (sustained abstinence).
Matching the clinical quotes to the defining characteristics of each stage ensures accurate categorization.
3
Sequence the categorized statements.
The correct sequence is Precontemplation -> Contemplation -> Preparation -> Action -> Maintenance.
This represents the classic progression from lacking awareness of a problem to achieving long-term recovery.

Key Concept

Transtheoretical Model (Stages of Change) in Substance Use Disorders
Question 691Question →

A 29-year-old man is brought to the emergency department by his partner due to a rapidly spreading rash and fever. Over the past 48 hours, he developed flu-like symptoms followed by painful, erythematous macules on his chest and back. Physical examination reveals a temperature of 39.2°C (102.6°F). The macules have coalesced into large areas of blistering, and the epidermis sloughs off with gentle lateral pressure. Ulcerations are visible on his buccal mucosa and vermilion border. The patient has a 4-year history of bipolar I disorder and has been maintained on divalproex sodium. Three weeks ago, he sought treatment for a severe depressive episode, and his psychiatrist added a second medication to his regimen. The new medication was prescribed at a starting dose of 25 mg daily. Which of the following pharmacokinetic or pharmacodynamic mechanisms best explains the pathogenesis of this patient's current dermatologic emergency?

Show answer & explanation

Answer: Inhibition of hepatic glucuronidation by the maintenance mood stabilizer

Answer

Inhibition of hepatic glucuronidation by the maintenance mood stabilizer
The correct answer is inhibition of hepatic glucuronidation by the maintenance mood stabilizer. The patient is presenting with Stevens-Johnson syndrome (SJS) or Toxic Epidermal Necrolysis (TEN), a life-threatening mucocutaneous reaction characterized by a blistering rash, mucosal ulcerations, and a positive Nikolsky sign. In the context of bipolar disorder, the most likely medication added for a depressive episode that causes SJS is lamotrigine. Lamotrigine is metabolized in the liver primarily by UDP-glucuronosyltransferase (UGT). The patient's maintenance medication, divalproex sodium (valproic acid), is a potent inhibitor of UGT. When lamotrigine is added to a valproate regimen without appropriate dose adjustments, its clearance is halved, leading to a rapid and dangerous increase in plasma lamotrigine levels. This significantly elevates the risk of SJS/TEN. Therefore, when initiating lamotrigine in a patient taking valproate, the starting dose must be reduced by 50% (typically 25 mg every other day) and titrated much more slowly.

Step-by-Step Solution

1
Identify the acute clinical syndrome based on the physical examination findings.
The patient has fever, a blistering rash with a positive Nikolsky sign (epidermal sloughing), and mucosal ulcerations, which is highly characteristic of Stevens-Johnson syndrome (SJS) or Toxic Epidermal Necrolysis (TEN).
Recognizing this dermatologic emergency is critical to identifying the offending pharmacological trigger.
2
Determine the most likely offending psychotropic medication added to the patient's regimen.
The patient was prescribed a medication for bipolar depression starting at 25 mg daily. Lamotrigine is a first-line treatment for bipolar depression and is known to carry a black box warning for SJS/TEN.
Connecting the psychiatric indication (bipolar depression) and the typical starting dose (25 mg) points directly to lamotrigine.
3
Analyze the pharmacokinetic interaction between the maintenance therapy and the newly added agent.
The patient was already on divalproex sodium (valproic acid). Valproic acid is a potent inhibitor of UDP-glucuronosyltransferase (UGT), the primary enzyme responsible for metabolizing lamotrigine.
Understanding drug metabolism is required to explain why standard dosing led to a toxic outcome in this specific patient.
4
Apply the interaction mechanism to the dosing error.
Because valproic acid inhibits UGT, it significantly decreases lamotrigine clearance. The standard starting dose of 25 mg daily is therefore too high in this context and leads to toxic lamotrigine levels, precipitating SJS/TEN. The dose should have been reduced by 50% (to 25 mg every other day).
This confirms that the inhibition of hepatic glucuronidation by the maintenance medication is the correct mechanism for the toxicity.

Key Concept

Valproic acid inhibits UDP-glucuronosyltransferase (UGT), which doubles the plasma concentration of concurrently administered lamotrigine. To mitigate the severe risk of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), the starting dose of lamotrigine must be reduced by 50% when a patient is taking valproic acid.
Question 692Question →

A 36-year-old woman presents to the primary care clinic reporting a 5-week history of profound sadness, early morning awakening, decreased appetite, and difficulty concentrating at work. She states she has never felt this way before and denies any current suicidal ideation, hallucinations, or delusions. Her medical history is unremarkable, and she takes no medications. The physician determines she is experiencing a major depressive episode and considers initiating fluoxetine therapy. Which of the following is the most appropriate next step in the clinical care of this patient?

Show answer & explanation

Answer: Assess for a history of discrete periods characterized by abnormally elevated mood and impulsivity

Answer

Assess for a history of discrete periods characterized by abnormally elevated mood and impulsivity.
The most important next step in evaluating a patient presenting with a major depressive episode is to screen for a history of manic or hypomanic episodes. A patient with a history of mania who is currently depressed has bipolar I disorder, not major depressive disorder. Differentiating between unipolar and bipolar depression is critical because the treatment algorithms differ significantly. Initiating antidepressant monotherapy (such as fluoxetine) in a patient with bipolar disorder is contraindicated because it can precipitate a manic episode (manic switch) and increase mood instability. Therefore, assessing for periods of elevated mood, impulsivity, and decreased need for sleep must occur before writing the prescription.

Step-by-Step Solution

1
Diagnose the current episode
The patient meets criteria for a major depressive episode (at least 2 weeks of depressed mood/anhedonia plus associated symptoms like insomnia, weight loss, and poor concentration).
Establishing the current syndromal presentation is the first step in psychiatric evaluation.
2
Differentiate between unipolar and bipolar depression
The physician must actively screen for any past episodes of mania or hypomania.
A major depressive episode can occur in both Major Depressive Disorder (unipolar) and Bipolar Disorder. The treatments for these two conditions are fundamentally different.
3
Determine appropriate pharmacological safety
Initiating an SSRI (like fluoxetine) without ruling out bipolar disorder is unsafe.
Antidepressant monotherapy in a patient with undiagnosed bipolar disorder can precipitate a manic episode (manic switch) and lead to rapid cycling.

Key Concept

Prior to initiating antidepressant therapy for a depressive episode, patients must be screened for a history of mania or hypomania to avoid precipitating a manic episode.
Estimated Time:1m 15s
Question 693Question →

A 20-year-old college sophomore presents to the student health clinic reporting intense fear and physical distress regarding an upcoming mandatory oral presentation scheduled in four days. He describes experiencing severe palpitations, visible hand tremors, and a "knot in his stomach" whenever he thinks about standing in front of his classmates. He states, "I know my fear is irrational, but I am terrified they will see me shaking and think I am incompetent." He has no anxiety in social gatherings, on dates, or in other academic settings. His medical history is significant for moderate persistent asthma, which is well-controlled with a daily fluticasone-salmeterol inhaler and albuterol as needed. He does not use illicit substances or alcohol. Vital signs are within normal limits. Which of the following is the most appropriate pharmacological intervention to manage his symptoms for the upcoming presentation?

Show answer & explanation

Answer: Prescription for lorazepam to be taken prior to the presentation

Answer

The most appropriate management is a prescription for a short-acting benzodiazepine, such as lorazepam, to be taken prior to the presentation.
The correct answer provides a safe and effective immediate treatment. The patient presents with performance-only social anxiety disorder (SAD). While beta-blockers are generally the first-line targeted pharmacotherapy for this condition, this patient's history of asthma represents a strict contraindication to non-selective beta-blockers like propranolol due to the risk of severe bronchospasm. In cases where beta-blockers cannot be used and there is no history of substance abuse, a short-acting benzodiazepine (such as lorazepam or clonazepam) taken occasionally before the triggering event is the most appropriate alternative to suppress the autonomic and psychological symptoms of acute anxiety.

Step-by-Step Solution

1
Diagnose the primary psychiatric condition based on the patient's specific symptom triggers.
The patient experiences intense autonomic arousal strictly associated with public speaking, consistent with performance-only social anxiety disorder.
Accurate subtyping of social anxiety disorder is required to select the correct pharmacological pathway.
2
Identify the standard first-line treatment for this specific diagnosis.
Beta-blockers, such as propranolol, are typically the treatment of choice for managing the acute autonomic symptoms of performance anxiety.
Establishing the standard of care provides a baseline for management decisions.
3
Evaluate the patient's medical history for contraindications to the standard treatment.
The patient has moderate persistent asthma. Non-selective beta-blockers like propranolol are strictly contraindicated due to the high risk of inducing severe bronchospasm.
Patient safety requires recognizing systemic medical comorbidities that preclude standard psychiatric therapies.
4
Select the most appropriate, safe alternative therapy for the acute event.
A short-acting benzodiazepine (e.g., lorazepam) taken as needed prior to the performance is the safest alternative to achieve rapid anxiolysis.
Benzodiazepines provide targeted symptom relief without exacerbating airway resistance.

Key Concept

Management of performance-only social anxiety disorder in patients with contraindications to beta-blockers
Estimated Time:1m 15s
Question 694Question →

A kindergarten teacher raises concerns about a 5-year-old boy who recently transferred to her classroom. The child rarely initiates play with peers, often avoids eye contact when addressed, and frequently flaps his hands when excited. The school psychologist and pediatrician collaborate to evaluate him for Autism Spectrum Disorder (ASD). When distinguishing ASD from an isolated speech delay or global developmental delay, which of the following findings would specifically fulfill the core diagnostic criteria for ASD? (Select all that apply)

Select all that apply

Show answer & explanation

Answer: Consistent lack of joint attention, such as failing to point at objects of interest to share them with others; Extreme emotional distress and tantrums when the standard classroom routine is slightly altered; Highly restricted preoccupation with the exact scheduling of local train departures

Answer

The findings that specifically support an ASD diagnosis are the consistent lack of joint attention, extreme emotional distress when routines are altered, and highly restricted preoccupations with train schedules.
Autism Spectrum Disorder is characterized by specific qualitative impairments rather than just delayed milestone acquisition. To establish the diagnosis, a patient must demonstrate persistent deficits in social communication (such as a lack of joint attention) AND restricted, repetitive patterns of behavior, interests, or activities (such as an inflexible adherence to routines and highly fixated interests). These specific behavioral features distinguish ASD from isolated developmental delays.

Step-by-Step Solution

1
Analyze the core diagnostic criteria for Autism Spectrum Disorder (ASD) according to the DSM-5.
ASD requires two main symptom domains: (1) persistent deficits in social communication and social interaction, and (2) restricted, repetitive patterns of behavior, interests, or activities.
Establishing the required diagnostic domains is the first step in differentiating ASD from other neurodevelopmental disorders.
2
Evaluate the clinical findings against the social communication domain.
A consistent lack of joint attention (e.g., not pointing to share an interest) is a hallmark deficit in social-emotional reciprocity and nonverbal communication specific to ASD.
This qualitative impairment distinguishes ASD from pure speech or language disorders where children still attempt to communicate nonverbally.
3
Evaluate the clinical findings against the restricted/repetitive behaviors domain.
Extreme distress with routine changes (insistence on sameness) and fixated interests (preoccupation with train schedules) specifically fulfill the requirements for this second diagnostic domain.
These behaviors are highly specific to ASD and are not typical features of isolated developmental delays.
4
Differentiate the core ASD features from standard milestone delays.
Inability to copy shapes or having a limited vocabulary represent delayed motor and language milestones, respectively.
While children with ASD may have concurrent milestone delays, quantitative delays alone point toward a global developmental delay and do not fulfill the specific qualitative behavioral criteria required for an ASD diagnosis.

Key Concept

Diagnostic criteria for Autism Spectrum Disorder
Question 695Question →

For the following individuals presenting with psychiatric symptoms, select the most accurate diagnosis by pairing the clinical history with the corresponding condition.

Click a left item, then click its matching right item

Items

A 22-year-old graduate student developed auditory hallucinations and the belief that the government is monitoring his thoughts. These symptoms have been present for 3 months, leading to a significant decline in his academic performance. He has no history of manic or depressive episodes.
A 47-year-old accountant firmly believes that a famous actor is secretly in love with her, sending her hidden messages through television interviews. She has held this belief for 8 months. She has no hallucinations, and her occupational functioning remains completely intact.
A 28-year-old woman with a history of major depressive episodes presents with auditory hallucinations. Medical records show she experienced these hallucinations for a 4-week period last year during which her mood was entirely euthymic, followed by a severe depressive episode.
A 19-year-old college freshman abruptly develops disorganized speech, agitation, and paranoid delusions two days after surviving a severe car accident. The symptoms completely resolve within 18 days, and he returns to his baseline level of functioning.

Matches

Show answer & explanation

Answer

The 22-year-old graduate student matches with Schizophreniform disorder; the 47-year-old accountant matches with Delusional disorder; the 28-year-old woman matches with Schizoaffective disorder; and the 19-year-old freshman matches with Brief psychotic disorder.
Each presentation strictly corresponds to DSM-5 timeline and criteria for psychotic disorders: <1 month is brief psychotic disorder, 1-6 months is schizophreniform disorder, >1 month of isolated delusions is delusional disorder, and psychosis independent of mood episodes characterizes schizoaffective disorder.

Step-by-Step Solution

1
Analyze the duration and symptom profile for the first presentation.
Symptoms match schizophrenia but have only lasted 3 months.
Duration between 1 and 6 months distinguishes schizophreniform disorder from schizophrenia (which requires >6 months).
2
Evaluate the second presentation focusing on functioning and symptom scope.
Isolated delusion for >1 month with preserved functioning.
These are the core criteria for delusional disorder.
3
Assess the third presentation for the relationship between psychosis and mood.
Psychosis occurs both with and without a mood episode (at least 2 weeks of psychosis without mood symptoms).
This temporal relationship is necessary to diagnose schizoaffective disorder.
4
Examine the fourth presentation's onset and duration.
Acute onset following a stressor, resolving within 18 days.
Psychotic symptoms lasting less than 1 month followed by full recovery characterize brief psychotic disorder.

Key Concept

Differentiating psychotic disorders based on symptom duration and the temporal relationship to mood episodes.
Question 696Question →

A 52-year-old man is brought to the emergency department by his husband due to severe confusion, agitation, and visual hallucinations. The husband reports that the patient has a history of bipolar disorder and has been hospitalized twice in the past for manic episodes. The patient recently experienced a severe depressive episode and was started on fluoxetine three weeks ago by a new provider. The patient also has a severe alcohol use disorder but abruptly stopped drinking 72 hours ago. On physical examination, the patient is profoundly diaphoretic, tremulous, and continuously picks at his skin, claiming there are "spiders everywhere." His temperature is 38.8°C (101.8°F), blood pressure is 158/96 mm Hg, pulse is 118/min, and respirations are 20/min. Physical examination reveals no nuchal rigidity, clear lungs to auscultation bilaterally, and a benign abdomen. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Administer intravenous diazepam

Answer

Administer intravenous diazepam
The most appropriate next step in management is the administration of an intravenous benzodiazepine, such as diazepam. This patient is experiencing delirium tremens (DTs), a severe and potentially fatal manifestation of alcohol withdrawal. Symptoms typically emerge 48 to 96 hours after the last drink and include severe agitation, confusion, visual hallucinations (such as seeing insects or spiders, known as formication), and marked autonomic hyperactivity (high fever, tachycardia, hypertension, and diaphoresis). The pathophysiology involves a hyper-excitable central nervous system due to the abrupt removal of alcohol's inhibitory effects on down-regulated GABA-A receptors, combined with an up-regulation of excitatory NMDA glutamate receptors. Immediate administration of intravenous benzodiazepines is the gold standard of care. Benzodiazepines substitute for the absent alcohol by stimulating GABA-A receptors, thereby reducing agitation, controlling autonomic instability, and preventing withdrawal seizures.

Step-by-Step Solution

1
Identify the patient's clinical syndrome based on the timeline of symptoms and physical exam findings.
The patient presents with severe agitation, visual hallucinations (formication), and profound autonomic hyperactivity (fever, tachycardia, hypertension) exactly 72 hours after abrupt cessation of heavy alcohol use. This is the classic presentation of delirium tremens (DTs).
Accurate diagnosis of the toxidrome or withdrawal state is required to initiate life-saving, specific pharmacological management.
2
Determine the first-line, acute pharmacological treatment for delirium tremens.
Long-acting benzodiazepines, such as intravenous diazepam or chlordiazepoxide, are the gold standard treatment.
Benzodiazepines mitigate the severe central nervous system excitation caused by GABA down-regulation during chronic alcohol use, thereby controlling agitation and preventing withdrawal seizures and cardiovascular collapse.

Key Concept

Delirium tremens typically occurs 48 to 96 hours after alcohol cessation and is characterized by autonomic hyperactivity and delirium. It is a life-threatening medical emergency treated with intravenous benzodiazepines.
Question 697Question →

A primary care physician evaluates a 29-year-old female patient complaining of unrelenting anxiety regarding her job security, personal finances, and general health that has persisted for the past 9 months. She describes experiencing frequent muscle tension, daytime fatigue, and poor concentration. During the psychiatric history, she mentions that 4 years ago she had a distinct 14-day period where she "felt invincible," required only 90 minutes of sleep per night, and maxed out her credit cards on impulsive purchases. She states her mood is currently euthymic. Her past medical history is notable for a methicillin-resistant Staphylococcus aureus (MRSA) skin infection, for which she was prescribed linezolid 3 days ago. Which of the following are appropriate considerations regarding this patient's diagnosis and management? (Select exactly 2 options)

Select all that apply

Show answer & explanation

Answer: Engagement in cognitive-behavioral therapy as a primary intervention for the anxiety symptoms; Avoidance of all serotonergic medications during the current antibiotic regimen

Answer

The correct management considerations are engagement in cognitive-behavioral therapy (CBT) and the strict avoidance of serotonergic medications during her linezolid therapy.
This patient presents with symptoms of Generalized Anxiety Disorder (GAD) in the context of a history of Bipolar I Disorder (evidenced by the prior manic episode) and current linezolid therapy. Cognitive-behavioral therapy (CBT) is an evidence-based, first-line treatment for GAD that avoids the risk of inducing a manic switch. Furthermore, linezolid is a weak, reversible monoamine oxidase inhibitor (MAOI). Co-administering any serotonergic medication (like an SSRI or SNRI) with linezolid is strictly contraindicated due to the high risk of precipitating life-threatening serotonin syndrome.

Step-by-Step Solution

1
Analyze the current psychiatric presentation.
The patient has 9 months of excessive worry, muscle tension, fatigue, and poor concentration, meeting DSM-5 criteria for Generalized Anxiety Disorder (GAD).
To establish the primary target for current intervention.
2
Evaluate the historical psychiatric episode.
The 14-day period of decreased need for sleep, grandiosity, and impulsive behavior indicates a past manic episode, establishing a background diagnosis of Bipolar I Disorder.
To identify contraindications for pharmacotherapy, such as the risk of antidepressant-induced mania.
3
Assess the current medication regimen for interactions.
The patient is taking linezolid, an antibiotic that also possesses reversible monoamine oxidase inhibitor (MAOI) properties.
To prevent potentially fatal drug-drug interactions when considering anxiolytic medications.
4
Determine the optimal management strategy.
CBT is a safe, effective first-line treatment for GAD. Serotonergic agents must be avoided currently (due to linezolid) and in the future as monotherapy (due to Bipolar I).
To treat the patient safely based on her complex pharmacological and psychiatric presentation.

Key Concept

Management of Anxiety Disorders in the context of Bipolar I Disorder and MAOI (linezolid) therapy
Question 698Question →

A 67-year-old man is evaluated by the consultation-liaison psychiatry team on the medical floor. He was admitted one week ago for a non-ST-elevation myocardial infarction and subsequently developed a complicated soft-tissue infection at the catheter insertion site, for which he is currently receiving intravenous linezolid. The nursing staff reports that the patient has been increasingly withdrawn, tearful, and refusing to participate in physical therapy. During the interview, the patient is fully oriented and demonstrates intact decision-making capacity. He reports a two-month history of a profoundly depressed mood, pervasive anhedonia, early morning awakenings, a 5-kg (11-lb) weight loss, and hearing a voice repeatedly telling him he is a "total failure." He states, "I just have no energy left to fight, but I definitely do not want any sort of shock treatments." His wife, who is present, privately tells the physician, "He doesn't know what he's saying. I give you full permission to do electroconvulsive therapy if it will fix this." Review of his past medical history reveals an episode at age 26 when he was hospitalized for a week after staying awake for five consecutive days and recklessly spending his life savings on an impulsive business venture. Which of the following is the most appropriate next step in the psychiatric management of this patient?

Show answer & explanation

Answer: Initiate quetiapine therapy

Answer

Initiate quetiapine therapy
The patient's presentation of a major depressive episode with a historical manic episode confirms a diagnosis of Bipolar I Disorder, currently in a depressed phase with psychotic features. Quetiapine is a first-line, FDA-approved monotherapy for bipolar depression that will also target his auditory hallucinations. Importantly, it avoids the risk of inducing a manic switch (seen with traditional antidepressants), respects his competent refusal of ECT, and does not carry an absolute contraindication with linezolid (unlike SSRIs/SNRIs, which risk serotonin syndrome).

Step-by-Step Solution

1
Analyze the psychiatric presentation and timeline.
The patient has a 2-month history of severe depression with psychotic features (auditory hallucinations).
Establishing the current syndrome is the first step in psychiatric diagnosis.
2
Screen past medical history for prior mood episodes.
The patient has a distinct history of a severe manic episode (hospitalization, decreased need for sleep, impulsivity) at age 26.
A single manic episode changes the diagnosis from Major Depressive Disorder to Bipolar I Disorder, fundamentally altering management.
3
Evaluate current non-psychiatric treatments for potential drug interactions.
The patient is receiving linezolid, an antibiotic that acts as a reversible, non-selective monoamine oxidase inhibitor (MAOI).
MAOIs combined with serotonergic agents (SSRIs, SNRIs) can cause fatal serotonin syndrome.
4
Assess the ethical and legal implications of the wife's request.
The patient has intact decision-making capacity and explicitly refuses electroconvulsive therapy (ECT).
Autonomy dictates that a competent patient's refusal of care supersedes a family member's wishes.
5
Select the optimal management strategy.
Quetiapine is selected.
As an atypical antipsychotic, it is first-line for bipolar depression, treats the psychotic features, avoids the risk of manic switch, and does not precipitate serotonin syndrome with linezolid.

Key Concept

Bipolar depression management requires avoiding antidepressant monotherapy due to manic switch risk; atypical antipsychotics effectively treat both mood and psychotic symptoms while respecting patient autonomy and avoiding critical pharmacological interactions.
Estimated Time:1m 30s
Question 699Question →

An outpatient psychiatrist is reviewing the longitudinal chart of a 34-year-old female patient who recently relocated to the area. Her psychiatric symptoms began 5 years ago. During this time, she has experienced recurrent, distinct episodes characterized by pervasive sadness, insomnia, poor appetite, and suicidal ideation. According to her medical records, these mood episodes cumulatively account for approximately 4 years of her clinical history. She has never had an episode of elevated mood, impulsivity, or a decreased need for sleep. The charts clearly document that on two separate occasions—each lasting approximately 4 to 6 weeks—her mood symptoms completely resolved following medication adjustments. However, during both of these specific periods of euthymia, she continued to experience prominent auditory hallucinations and the steadfast delusion that the government was monitoring her thoughts. Based on the patient's longitudinal history, which of the following is the most accurate diagnosis?

Show answer & explanation

Answer: Schizoaffective disorder

Answer

Schizoaffective disorder
The correct answer is schizoaffective disorder because the patient's longitudinal history demonstrates two mandatory timeline criteria: (1) she experienced psychotic symptoms (hallucinations and delusions) for more than 2 weeks (4-6 weeks) while completely euthymic, and (2) her major depressive episodes have been present for the majority of the total duration of the illness (4 years out of a 5-year course). These features definitively separate her condition from pure mood disorders and schizophrenia, respectively.

Step-by-Step Solution

1
Analyze the total duration of the illness and the proportion of time the patient experienced mood symptoms.
The total illness duration is 5 years, and depressive episodes account for 4 years. Therefore, mood symptoms have been present for the majority of the total illness course.
Establishing the proportion of time mood symptoms are present is necessary to differentiate schizophrenia from schizoaffective disorder.
2
Determine if psychotic symptoms ever occurred independently of a major mood episode.
The patient had two separate 4-6 week periods where she experienced auditory hallucinations and delusions while her mood was completely normal (euthymic).
Identifying psychosis in the absence of a mood episode for at least 2 weeks differentiates schizoaffective disorder from a mood disorder with psychotic features.
3
Synthesize the timeline findings to formulate a definitive diagnosis.
Psychosis >2 weeks without mood symptoms PLUS mood symptoms present for the majority of the total illness duration strictly meets the criteria for schizoaffective disorder.
These dual criteria are the diagnostic hallmarks of schizoaffective disorder in the DSM-5-TR.

Key Concept

To diagnose schizoaffective disorder, a patient must have an uninterrupted period of illness featuring a major mood episode concurrent with psychotic symptoms, PLUS at least 2 weeks of delusions or hallucinations in the absence of a major mood episode, with mood symptoms present for the majority of the total illness duration.
Question 700Question →

Correlate each distinct clinical presentation observed in the acute care setting with the most accurate corresponding substance-related syndrome.

Click a left item, then click its matching right item

Items

Prominent rhinorrhea, frequent yawning, diffuse piloerection, and severe myalgias in an ambulatory patient.
Pronounced diaphoresis, pupillary dilation (mydriasis), resting tachycardia, and rapid, pressured speech in an agitated individual.
Rotary nystagmus, significant combativeness, and a striking lack of response to painful procedures in a trauma setting.
Development of a coarse resting hand tremor, diaphoresis, and new-onset hypertension in a hospitalized patient on post-operative day three.

Matches

Show answer & explanation

Answer

The clinical presentations map to the following syndromes: rhinorrhea, yawning, and piloerection indicate opioid withdrawal; diaphoresis, mydriasis, and pressured speech indicate stimulant intoxication; rotary nystagmus and analgesia indicate PCP intoxication; and post-operative tremor with hypertension indicates alcohol withdrawal.
Each syndrome is identifiable by unique hallmark features. Opioid withdrawal is defined by flu-like symptoms, yawning, and piloerection. Stimulant intoxication presents with generalized sympathetic overactivation, prominently featuring mydriasis and psychomotor agitation. PCP intoxication is virtually unique in causing rotary nystagmus coupled with extreme analgesia. Finally, unexpected alcohol withdrawal in hospitalized patients classically emerges 2 to 3 days after admission with a coarse tremor and autonomic instability.

Step-by-Step Solution

1
Analyze the first presentation for highly specific physical exam findings.
Identified piloerection (goosebumps) and yawning, which strongly point to opioid withdrawal.
These flu-like symptoms are the hallmark of the sympathetic rebound seen when opioids are discontinued.
2
Evaluate the second presentation focusing on pupillary and behavioral changes.
Mydriasis combined with pressured speech and tachycardia aligns with stimulant intoxication.
Cocaine and amphetamines block reuptake or stimulate release of catecholamines, causing pronounced sympathetic activation.
3
Examine the third presentation for neurological and sensory abnormalities.
Rotary nystagmus and profound analgesia point definitively to PCP intoxication.
PCP is an NMDA receptor antagonist that causes a unique dissociative state with characteristic multidirectional nystagmus.
4
Review the fourth presentation regarding the clinical timeline and symptoms.
A coarse tremor and autonomic instability on post-operative day three suggests alcohol withdrawal.
Hospital admission often forces abrupt alcohol cessation, leading to withdrawal syndromes classically emerging 48 to 72 hours later.

Key Concept

Clinical diagnosis of substance-induced toxidromes and withdrawal syndromes
PreviousPage 35 / 41Next
Psychiatry Practice Questions — USMLE Step 2 CK — Page 35 | Examkin